INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5116.39M
Enterprise Value 365.31M
Trailing P/E N/A
Forward P/E 1-3.80
PEG Ratio (5 yr expected) 1-0.03
Price/Sales (ttm)19.40
Price/Book (mrq)2.38
Enterprise Value/Revenue 310.88
Enterprise Value/EBITDA 6-1.88

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-607.42%

Management Effectiveness

Return on Assets (ttm)-24.62%
Return on Equity (ttm)-64.26%

Income Statement

Revenue (ttm)6M
Revenue Per Share (ttm)0.12
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)6M
EBITDA -34.73M
Net Income Avi to Common (ttm)-41.83M
Diluted EPS (ttm)-0.83
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)57.61M
Total Cash Per Share (mrq)1.11
Total Debt (mrq)6M
Total Debt/Equity (mrq)12.57
Current Ratio (mrq)5.03
Book Value Per Share (mrq)0.94

Cash Flow Statement

Operating Cash Flow (ttm)-36.71M
Levered Free Cash Flow (ttm)-24.21M

Trading Information

Stock Price History

Beta 2.51
52-Week Change 312.24%
S&P500 52-Week Change 313.44%
52 Week High 33.75
52 Week Low 30.93
50-Day Moving Average 32.28
200-Day Moving Average 32.11

Share Statistics

Avg Vol (3 month) 3766.81k
Avg Vol (10 day) 3629.34k
Shares Outstanding 551.96M
Float 38.77M
% Held by Insiders 12.43%
% Held by Institutions 155.72%
Shares Short 31.98M
Short Ratio 31.06
Short % of Float 34.72%
Shares Short (prior month) 32.07M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/4
Last Split Date 3Sep 13, 2006